Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

ConditionsAdvanced Cancer Pain

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age21+

SponsorDana-Farber Cancer Institute

About this trial

The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 21 years

Current or previous diagnosis of advanced cancer

Current or previous experience with cancer pain

Disqualifiers

Inability to understand, speak, or read English

Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.

Trial design

Design model

Single group

Treatments tested in this trial

I-STAMP
Behavioral
A patient-facing smartphone application that hosts participants' analgesic and laxative medications, provides pain-specific psychoeducation, collects patient reported outcomes, and provides feedback to participant symptoms.

Treatment groups

73 Participants

are divided into 1 treatment group

Group A: I-STAMP TestingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Usability

Patients will complete a validated 10-item system usability scale (SUS) with total scores ranging from 0-100, where a score of 100 being the best possible usability score.

Time frame

2 weeks

E-scale Acceptability

Patients will rate overall acceptability of the application using a modified acceptability e-scale. This 6-item measure asks patients to rate the app on ease of use, understandability, enjoyment, helpfulness, time spent, and overall satisfaction, on a 1 to 5 Likert scale. Items are summed to for a total score, ranging from 6 to 30 with 30 being the highest acceptability score.

Time frame

2 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Dana-Farber Cancer Institute

Lead sponsor

Source ClinicalTrials.gov

Apply now